Categories: Tech

Presidio Named AWS Generative AI Innovation Alliance Partner

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — Presidio, a leading technology services and solutions provider, today announced it has been selected as a Partner Innovation Alliance (PIA) partner within the AWS Generative AI Innovation Center (GenAIIC). This recognition underscores Presidio’s commitment to advancing artificial intelligence (AI) innovation and its deep collaboration with Amazon Web Services (AWS) to deliver transformative solutions for clients.

The GenAIIC connects customers with AWS AI/ML scientists and strategy experts, to help envision, identify, and develop generative AI solutions. Since its inception, the GenAIIC has helped thousands of organizations achieve success with generative AI. The AWS GenAIIC PIA designation is awarded to select partners who demonstrate exceptional capabilities in applying generative AI to solve complex business challenges and deliver both proof-of-concept and production ready implementations.

“Presidio’s inclusion in this elite group reflects our pioneering work to push the boundaries of what’s possible with AI,” said Chris Cagnazzi, Chief Innovation Officer at Presidio. “Our collaboration with AWS has enabled us to rapidly prototype, scale, and deliver innovative generative AI solutions that are closely aligned with our clients’ strategic goals. We’re honored to join the GenAIIC Partner Innovation Alliance and excited to continue shaping the future of AI together.”

By combining domain expertise, agile methodologies, and AWS’s powerful AI/ML services, Presidio empowers organizations to unlock new efficiencies, enhance decision-making, and create differentiated customer experiences.

As a GenAIIC PIA partner, Presidio will continue working closely with AWS to co-develop industry-specific solutions, share best practices, and accelerate AI adoption across the enterprise landscape. For more information about Presidio’s AI capabilities and partnership with AWS, visit https://www.presidio.com/partners/aws.

About Presidio

At Presidio, speed and quality meet technology and innovation. Presidio is a trusted ally for organizations across industries with a decades-long history of building traditional IT foundations and deep expertise in AI and automation, security, networking, digital transformation, and cloud computing. Presidio fills gaps, removes hurdles, optimizes costs, and reduces risk. Presidio’s expert technical team develops custom applications, provides managed services, enables actionable data insights, and builds forward-thinking solutions that drive strategic outcomes for clients globally. For more information, visit www.presidio.com.

Contacts:
Press: PR@Presidio.com
Investor Relations: Investors@presidio.com

GlobeNews Wire

Recent Posts

World Youth Skills Day 2025: Shanghai Electric Champions AI and Digital Skills with Global Innovation Tournament

Inspiring young talents to pioneer innovations in green technology, advanced manufacturing, and digital intelligence SHANGHAI,…

5 minutes ago

Penta Security Receives Frost & Sullivan’s 2025 South Korea Company of the Year Recognition for Excellence in Web Application Firewall Technology

Penta Security honored for its innovation-driven cybersecurity strategy, delivering intelligent threat detection and robust customer-centric…

6 minutes ago

Sammaan Capital Unveils ‘Hum Ho Gaye Kamyaab’ Campaign; Celebrating the Dreams and Success of India’s Middle Class

The new TVC honours the journey of India's resilient middle class — from aspirations to accomplishments,…

5 hours ago

NYSE Content Advisory: Pre-Market update + Wall Street readies for big bank earnings

NEW YORK, July 16, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

5 hours ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., July 18, 2025…

8 hours ago

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

July 18, 2025 16:05 ET  | Source: HOOKIPA Pharma Inc. NEW YORK and VIENNA, July…

8 hours ago